Omeprazole/Amoxicillin/Clarithromycin

Omeprazole/Amoxicillin/Clarithromycin

DEA Class; Rx

Common Brand Names; Omeclamox-Pak

  • H pylori Agents; 
  • PUD Combos

A triple-drug regimen pack containing an aminopenicillin (amoxicillin), a macrolide (clarithromycin), and a PPI (omeprazole)
Used for the eradication of H. pylori in adults
Triple-drug regimens are usually recommended by the American College of Gastroenterology (ACG) guidelines for managing H. pylori infection

Indicated for eradication of H pylori to reduce risk of duodenal ulcer recurrence

Coadministration with pimozide, ergotamine or dihydroergotamine

Omeprazole

  • • Hypersensitivity to omeprazole, benzimidazoles or other proton pump inhibitors

Amoxicillin

  • Allergy to penicillins, cephalosporins, imipenem

  • Infectious mononucleosis (relative)

  • Concomitant live bacterial vaccines

Clarithromycin

  • Clarithromycin/ranitidine bicitrate contraindicated in: severe renal impairment (CrCl<25 mL/min); history of acute porphyria

Clarithromycin

  • GI effects, general (13%)
  • Headache (2%)
  • Abdominal pain (2%)
  • Abnormal taste (3-7%)
  • Diarrhea (3-6%)
  • Dyspepsia (2%)
  • Heartburn (2%)
  • Nausea (3-6%)
  • Increased BUN (4%)
  • Increased PT (1%)
  • Vomiting (1%)
  • GI intolerance
  • Decrease WBC Rash
  • QT prolongation
  • Neurology/Psychiatric: Anxiety, dizziness, hallucinations, manic behavior, neuromuscular blockade, psychosis, seizures
  • Gastrointestinal: Anorexia, glossitis, pancreatitis, jaundice, hepatitis/hepatic dysfunction, C difficile colitis
  • Laboratory: Bilirubin increased, elevated AST, LFTs, alkaline phosphate, serum creatinine; hypoglycemia, leukopenia, neutropenia, thrombocytopenia
  • Anaphylaxis, dyspnea, Stevens-Johnson syndrome

Omeprazole

  • Acid regurgitation (1.9%)
  • Upper respiratory infection (1.9%)
  • Constipation (1.5%)
  • Dizziness (1.5%)
  • Rash (1.5%)
  • Asthenia (1.3%)
  • Back pain (1.1%)
  • Cough (1.1%)
  • Fracture of bone, osteoporosis-related
  • Hepatotoxicity (rare)
  • Hip fracture
  • Interstitial nephritis (rare)
  • Pancreatitis (rare)
  • Rhabdomyolysis
  • Toxic epidermal necrolysis (rare)

Amoxicillin

  • Headache
  • Rash
  • Diarrhea, nausea, vomiting
  • Anemia
  • AST/ALT elevation
  • Anaphylaxis
  • Candidiasis (mucocutaneous), pseudomembranous colitis, serum sickness

Omeprazole

  • Liver disease may require dosage reduction

  • Published observational studies suggest that proton pump inhibitor (PPI) therapy may be associated with an increased risk for osteoporosis-related fractures of the hip, wrist, or spine; particularly with prolonged (>1 yr), high-dose therapy

Amoxicillin

  • Allergy to cephalosporins, carbapenems

  • Endocarditis prophylaxis: use only for high-risk patients, per recent AHA Guidelines

  • High doses may cause false urine glucose test by some methods

Clarithromycin

  • Severe renal impairment

  • Do not refrigerate oral solution

  • Endocarditis prophylaxis: use only for high-risk patients, per recent AHA Guidelines

Pregnancy

Based on findings in animal studies for omeprazole and clarithromycin during pregnancy may cause fetal harm; therapy is not recommended for use in pregnant women except in clinical circumstances where no alternative therapy is appropriate

Based on limited human data, clarithromycin and its active metabolite 14-OH clarithromycin are present in human milk at less than 2% of maternal weight-adjusted dose

Adults

Amoxicillin 2000 mg/day PO; Clarithromycin 1 g/day PO; Omeprazole 40 mg/day PO.

Geriatric

Amoxicillin 2000 mg/day PO; Clarithromycin 1 g/day PO; Omeprazole 40 mg/day PO.

Adolescents

Safety and efficacy have not been established.

Children

Safety and efficacy have not been established.

Infants

Safety and efficacy have not been established.
 

Neonates

Safety and efficacy have not been established.

Omeprazole/amoxicillin/clarithromycin

capsule/capsule/tablet prepack

  • 20mg/500mg/500mg
  • Amoxicillin dose consists of two 500mg capsules (ie, 1000mg/dose)
DrugsAce
Logo